{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT03596372: Phase 1 Interventional Completed Advanced CEACAM6-expressing Solid Tumors
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:linavonkibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04207034: Not Applicable Interventional Unknown status Chronic Periodontitis
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:remternetug [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03797391: Phase 1/Phase 2 Interventional Recruiting Neoplasms
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02810418: Phase 1/Phase 2 Interventional Completed Neoplasms
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03611569: Phase 1 Interventional Completed Healthy
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03628053: Phase 3 Interventional Withdrawn Acute Lymphoblastic Leukemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:mibavademab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03838731: Phase 2 Interventional Completed Cat Allergy
(2019)
Source URL:
Class:
PROTEIN
